Multivessel Disease and Percutaneous Coronary Intervention

Cardiovascular disorders, such as heart failure and stroke, are the main causes of death and disability around the world. Read this report to learn more about multi-vessel coronary disease.

Coronary heart disease (CHD), also known as coronary artery disease (CAD), is the most common cause of major acute cardiac events (MACE). Atherosclerotic plaques build up in the walls of coronary arteries, preventing oxygen-rich blood from reaching the heart muscles. When heart tissues aren’t well nourished, they become fragile or impaired. Ischemia is caused by a lack of blood flow to the myocardium, while myocardial infarction is caused by a complete blockage (heart attacks). In certain cases, stenosis affects more than one major vessel (a major epicardial vessel has 70% or greater stenosis, whereas other major vessels have 50% or greater stenosis), indicating the existence of severe multivessel disease (MVD). The magnitude and severity of such culprit lesions must be determined in order to determine the best course of action for each CAD patient.Kindly visit Advanced Heart And Vascular Of Central New Jersey to find more information.

Electrocardiography (ECG), echocardiography, chest X-rays, and blood tests are some of the popular diagnostic procedures used by doctors following a physical examination and review of a patient’s medical history. The treatment choices for Coronary artery disease (CAD) are medical therapy and revascularization procedures, from which the cardiologist can select the best course of action based on the diagnostic test results and current medical condition. With a 0.75 cutoff value, the pressure-derived Ffr catheterization technique has aided interventional cardiologists in demonstrating or excluding ischemic lesions. To treat symptomatic multivessel disease, however, assessing the best risk stratification strategy can be difficult. The superiority of well-validated FFR catheterization over angiography in multivessel evaluation has been demonstrated in FAME (Fractional Flow Reserve versus Angiography in Multivessel Evaluation) studies, but the best revascularization approach for MVD remains a contentious issue.

Though FFR-guided percutaneous cardiac intervention (PCI) is the favoured revascularization treatment for single-vessel coronary disease, a definitive strategy for multi-vessel coronary disease is still being established. Until recently, coronary artery bypass grafting (CABG) was considered the “gold standard” for treating multi-vessel heart disease. Multi-vessel PCI has demonstrated improved outcomes comparable to CABG with the implementation of advanced stenting technology, imaging driven percutaneous cardiac intervention, and drug eluting stents.

Coronary Heart Disease, which is caused by the buildup of atherosclerotic plaque in the inner walls of coronary arteries, is a common heart condition that affects millions of people around the world. The fields of heart research and interventional cardiology have been working hard to come up with the best way to treat coronary artery disease (CAD). In most cases, determining the physiological significance and severity of lesions is difficult, which is why the pressure-based Fractional Flow Reserve measurement method was developed. In determining between coronary stenting and medical therapy, FFR is a well-validated index. It is now regarded as an important clinical method in the catheterization laboratory.